VERV•benzinga•
HC Wainwright & Co. Maintains Buy on Verve Therapeutics, Raises Price Target to $25
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 14, 2025 by benzinga